ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts6568
Avg. Estimate-0.21-0.24-0.86-0.97
Low Estimate-0.24-0.27-0.92-1.24
High Estimate-0.14-0.2-0.77-0.71
Year Ago EPS-0.2-0.23-1.1-0.86
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts6478
Avg. Estimate1.7M530k3.05M8.43M
Low Estimate200k200k1.74M4.85M
High Estimate8.5M1.1M10M13.3M
Year Ago Sales740k343k8M3.05M
Sales Growth (year/est)129.70%54.50%-61.90%176.40%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.2-0.24-0.2-0.21
EPS Actual-0.2-0.23-0.2-0.21
Difference00.0100
Surprise %0.00%4.20%0.00%0.00%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.21-0.24-0.86-0.97
7 Days Ago-0.21-0.24-0.86-0.97
30 Days Ago-0.18-0.25-0.84-0.95
60 Days Ago-0.17-0.21-0.83-0.77
90 Days Ago-0.17-0.21-0.83-0.77
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 Days1111
Up Last 30 Days2121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACRXIndustrySectorS&P 500
Current Qtr.-5.00%N/AN/A0.47
Next Qtr.-4.30%N/AN/A0.33
Current Year21.80%N/AN/A0.20
Next Year-12.80%N/AN/A0.07
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A